Projects per year
Personal profile
Education
- 1988-1993 Ph.D., Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University
- 1982-1985 M.S., Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University
- 1975-1982 M.D., School of Medicine, China Medical College
Experience
- 2019.08- Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2017.08- Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2016.08-2016.10 Acting Director, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02-2018.07 Director, Department of Pathology, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2013.09- Deputy Director, College of Medicine, Taipei Medical university
- 2010.11- Deputy Director, Center for Teaching and Learning Development, Office of Academic Affairs, Taipei Medical University
- 2007.08- Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2006.07-2010.07 Director, Center for Faculty Development, Taipei Municipal WanFang Hospital, Taipei Medical University
- 2007.04-2009.12 Committee member, OSCE committee, Taiwan Society of Medical Education
- 2007.03-2010.07 Director, Medical Education and Research, Taipei Municipal WanFang Hospital, Taipei Medical University
- 2005.04-2010.07 Director, Clinical Skill Center and OSCE Center, Taipei Municipal WanFang Hospital, Taipei Medical University
- 2003.09-2014.10 Director, Department of Pathology, Taipei Municipal WanFang Hospital, Taipei Medical University
- 2003.08 Professor, Department of Pathology, School of Medicine, Taipei Medical University
- 2002.08-2003.07 Director, Adjunct Professor, Department of Pathology, China Medical University Hospital
- 1999.10-2003.08 Director, Department of Pathology, China Medical University Hospital
- 1999-2001 Chief and Associate Professor, Department of Pathology, China Medical College Hospital
- 1996-1997 Research Fellow of Cardiovascular Pathology and Transplantation Immunology, Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, U.S.A.
- 1994.02-1999.09 Associate Professor, Department of Pathology, National Taiwan University College of Medicine
- 1990-1992 Research Fellow, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, U.S.A.
- 1986.08-1994.01 Instructor, Department of Pathology and Gradutate Institute of Pathology, National Taiwan University College of Medicine
Awards
- 2013 The Best Teaching Attending Physician Award, Taipei Medical University-Shuang Ho Hospital
- 2010.08 The Faculty Award, Taipei Medical University
- 2009 The Faulty Teaching Award, Taipei Municipal WanFang Hospital
- 2009 The Faulty Teaching Award, Taipei Medical University
- 2006.02 The Faulty Teaching Award, Taipei Municipal WanFang Hospital
- 2005 The Faulty Teaching Award, Taipei Municipal WanFang Hospital
- 2005 Outstanding Award of Contest of Published Paper and Posters, Taipei WanFang Hospital
- 1994 Professor Shu Yeh’s Award in Pathology (Ph.D. Section)
- 1987 Professor Shu Yeh’s Award in Pathology for Outstanding Pathology Research
- 1986 Qualified Pathologist in Taiwan (No. 063)
- 1986 Professor Shu Yeh’s Award in Pathology (Graduate Student Section)
Research Interests
- Pathology
- Oncologic Pathology
- Novel biomarkers in cancers
Fingerprint
Dive into the research topics where Chi-Long Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
-
RAB3C對大腸直腸癌之抗藥性與腫瘤免疫反應影響之探討(1/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Molecular Mechanisms of Secretory Rab Gtpase 3c in Promoting Colon Cancer Metastasis(3/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Molecular Mechanisms of Secretory Rab Gtpase 3c in Promoting Colon Cancer Metastasis
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Molecular Mechanisms of Secretory Rab Gtpase 3c in Promoting Colon Cancer Metastasis(1/3)
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Identification and Characterization of Ddx3 Downstream Epithelial-Mesenchymal Transition (Emt) Targets in Colorectal Cancer Metastasis
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
-
An annotation-free whole-slide training approach to pathological classification of lung cancer types using deep learning
Chen, C. L., Chen, C. C., Yu, W. H., Chen, S. H., Chang, Y. C., Hsu, T. I., Hsiao, M., Yeh, C. Y. & Chen, C. Y., Dec 2021, In: Nature Communications. 12, 1, 1193.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
High-grade b-cell lymphoma (Hgbl) with myc and bcl2 and/or bcl6 rearrangements is predominantly bcl6-rearranged and bcl6-expressing in Taiwan
Tsai, C. C., Su, Y. C., Bamodu, O. A., Chen, B. J., Tsai, W. C., Cheng, W. H., Lee, C. H., Hsieh, S. M., Liu, M. L., Fang, C. L., Lin, H. T., Chen, C. L., Yeh, C. T., Lee, W. H., Ho, C. L., Lai, S. W., Tzeng, H. E., Hsieh, Y. Y., Chang, C. L., Zheng, Y. M. & 4 others, , Apr 1 2021, In: Cancers. 13, 7, 1620.Research output: Contribution to journal › Article › peer-review
Open Access -
Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis
Kao, W. Y., Lin, Y. F., Chang, I. W., Chen, C. L., Tang, J. H., Chang, C. C., Chang, Y. J. & Wang, W., Mar 2021, In: Journal of the Chinese Medical Association. 84, 3, p. 261-266 6 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Monoamine oxidase b expression correlates with a poor prognosis in colorectal cancer patients and is significantly associated with epithelial-to-mesenchymal transition-related gene signatures
Yang, Y. C., Chien, M. H., Lai, T. C., Su, C. Y., Jan, Y. H., Hsiao, M. & Chen, C. L., Apr 2 2020, In: International journal of molecular sciences. 21, 8, 2813.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Quantitative analysis of intraoperative electrocorticography mirrors histopathology and seizure outcome after epileptic surgery in children
Peng, S. J., Wong, T. T., Huang, C. C., Chang, H., Hsieh, K. L. C., Tsai, M. L., Yang, Y. S. & Chen, C. L., 2020, (Accepted/In press) In: Journal of the Formosan Medical Association.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Supplementary Material for: The Aurora Kinases Inhibitor VE-465 is a Novel Treatment for Glioblastoma Multiforme
Lee, P. (Contributor), Chen, C. (Contributor), Lin, Z. (Contributor), Cheng, A. L. (Contributor), Chen, E. (Contributor), Whang-Peng, J. (Contributor) & Huang, C. (Contributor), Unknown Publisher, Jan 1 2013
DOI: 10.6084/m9.figshare.5124601.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_The_Aurora_Kinases_Inhibitor_VE-465_is_a_Novel_Treatment_for_Glioblastoma_Multiforme/5124601/1
Dataset
-
Additional file 1: Figure S1. of DEF6 expression in ovarian carcinoma correlates with poor patient survival
Liew, P. (Contributor), Fang, C. (Contributor), Lee, Y. (Contributor), Lee, Y. (Contributor), Chen, C. (Contributor) & Chu, J. (Contributor), Unknown Publisher, Aug 3 2016
DOI: 10.6084/m9.figshare.c.3607517_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_Figure_S1_of_DEF6_expression_in_ovarian_carcinoma_correlates_with_poor_patient_survival/4352030/1
Dataset
-
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis
Chang, Y. (Contributor), Chi, L. (Contributor), Chang, W. (Contributor), Su, C. (Contributor), Lin, Y. (Contributor), Chen, C. (Contributor), Chen, M. (Contributor), Chang, P. (Contributor), Wu, T. A. (Contributor) & Hsiao, M. (Contributor), Unknown Publisher, Jan 7 2017
DOI: 10.6084/m9.figshare.c.3660368.v1, https://figshare.com/collections/Glucose_transporter_4_promotes_head_and_neck_squamous_cell_carcinoma_metastasis_through_the_TRIM24-DDX58_axis/3660368/1
Dataset
-
Additional file 1: Table S1. of Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis
Chang, Y. (Contributor), Su, C. (Contributor), Chen, M. (Contributor), Chen, W. (Contributor), Chen, C. (Contributor) & Hsiao, M. (Contributor), Unknown Publisher, Aug 7 2017
DOI: 10.6084/m9.figshare.c.3845803_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Secretory_RAB_GTPase_3C_modulates_IL6-STAT3_pathway_to_promote_colon_cancer_metastasis_and_is_associated_with_poor_prognosis/5284759/1
Dataset
-
Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis
Chang, Y. (Contributor), Su, C. (Contributor), Chen, M. (Contributor), Chen, W. (Contributor), Chen, C. (Contributor) & Hsiao, M. (Contributor), Unknown Publisher, Aug 7 2017
DOI: 10.6084/m9.figshare.c.3845803.v1, https://figshare.com/collections/Secretory_RAB_GTPase_3C_modulates_IL6-STAT3_pathway_to_promote_colon_cancer_metastasis_and_is_associated_with_poor_prognosis/3845803/1
Dataset